Most startups burn cash on research and development long before they earn a dollar of revenue. That spending shapes your product, your pitch deck, and eventually your financial statements. Yet the accounting treatment for R&D catches many founders off guard. Under U.S. GAAP, the rules are stricter than you'd expect, and getting them wrong can create headaches during your next fundraise or audit. Whether you're building software, developing hardware prototypes, or running clinical trials, knowing how to properly account for R&D expenses is essential for early-stage companies. The treatment affects your income statement, your tax position, and how investors read your burn rate. This guide walks you through the correct journal entries, common pitfalls, and the moments where the rules shift beneath your feet. If you're a founder or early-stage finance lead who's been winging it with a spreadsheet, this is your starting point. We'll keep it practical: real entries, real mistakes, and real triggers that change the accounting. Your CPA will thank you later.
R&D expense covers costs tied to discovering new knowledge or developing new products, processes, or services. Think salaries for engineers, cloud computing costs for prototyping, lab supplies, and contractor fees for experimental work. Startups encounter these costs from day one, often before they have any revenue to show for it.
The tricky part? Under ASC 730, nearly all R&D costs must be expensed as incurred. You can't capitalize them onto your balance sheet and amortize them over time, with a narrow exception for software development costs once technological feasibility is established. That surprises founders who assume their biggest investment is building an asset.
Here's the high-level process: identify which costs qualify as R&D under GAAP, expense them in the period incurred, record the proper journal entries to an R&D expense account, and disclose them correctly on your income statement. If you're also claiming the federal R&D tax credit under Section 41, you'll need detailed documentation of qualified research activities. The expense treatment is straightforward once you understand the boundary between research and non-research spending. Keep reading for the specific entries and the exceptions that trip startups up.
Under ASC 730 (Accounting for Research and Development Costs), the default rule is simple: expense it. R&D costs hit your income statement in the period you incur them. They don't sit on the balance sheet as an asset.
The accounts affected are straightforward. You'll debit an R&D expense account (an operating expense on the income statement) and credit cash, accounts payable, or accrued liabilities depending on when and how you pay. If you're allocating employee salaries, you'll credit a wages payable or payroll liability account.
Here's a sample journal entry for $25,000 in monthly R&D costs:
| Account | Debit | Credit |
|---|---|---|
| R&D Expense | $25,000 | |
| Cash / Accounts Payable | $25,000 |
This entry recognizes the full cost immediately. There's no depreciation schedule, no amortization period. The expense reduces your net income (or increases your net loss) in the current period.
One critical nuance: if you purchase equipment that has an alternative future use beyond the R&D project, you capitalize that equipment as a fixed asset and depreciate it normally. The depreciation allocated to R&D activities then gets classified as R&D expense. But equipment with no alternative future use? Expense it immediately.
For software startups, ASC 985-20 and ASC 350-40 carve out specific rules. Internal-use software costs can be capitalized once the preliminary project stage ends and management commits to funding the project. Software developed for sale follows a different threshold tied to technological feasibility. These distinctions matter enormously for SaaS companies.
Capitalizing costs that should be expensed. Many founders treat R&D spending like a capital investment because it feels like one. Under GAAP, unless a specific exception applies (like internal-use software past the preliminary stage), you must expense these costs immediately. Capitalizing them inflates your assets and misrepresents your financial position.
Mixing R&D with general and administrative expenses. Engineering salaries sometimes get lumped into G&A, especially at small startups where engineers wear multiple hats. If an employee spends 70% of their time on qualified research activities, that portion belongs in R&D expense. Misclassification distorts your operating metrics and can cause problems with R&D tax credit claims.
Ignoring the alternative-future-use test for equipment. Startups sometimes expense every piece of lab equipment or hardware purchased for a project. If that equipment can be repurposed after the project ends, it should be capitalized and depreciated. The depreciation charge then flows through R&D expense. Getting this wrong affects both your balance sheet and your expense timing.
The biggest trigger for a change in R&D accounting treatment involves software development. For internal-use software under ASC 350-40, costs incurred during the preliminary project stage are expensed. Once you move into the application development stage, where you've committed to funding and the project's conceptual design is complete, you begin capitalizing costs. Those capitalized costs are then amortized over the software's estimated useful life once it's ready for its intended use.
For software sold to customers, the trigger under ASC 985-20 is technological feasibility. Before that milestone, everything is expensed. After it, certain production costs can be capitalized.
Acquisitions also shift the picture. If your startup acquires in-process R&D through a business combination, ASC 805 requires you to recognize it as an intangible asset at fair value on the acquisition date rather than expensing it immediately.
Not all platforms handle R&D classification well, so here's what to look for in your accounting software.
Automatic cost categorization. Good software recognizes common R&D cost patterns: engineering payroll, cloud infrastructure tied to development environments, and contractor payments tagged to research projects. It should route these to the correct expense accounts without manual reclassification every month.
Time allocation tracking. When employees split their time between R&D and other functions, your software should support percentage-based allocation. This keeps your R&D expense accurate and creates the documentation trail you need for tax credit claims under Section 41.
Stage-based capitalization rules. For software companies, the platform should distinguish between preliminary stage costs (expensed) and application development stage costs (capitalized). It should prompt you when a project's status changes and adjust the accounting treatment accordingly, rather than forcing you to remember and manually switch.
Is R&D expense a debit or credit?
R&D expense is a debit. Like all expenses, it increases with a debit entry and decreases your net income. The offsetting credit goes to cash, accounts payable, or a liability account depending on the payment method. On your income statement, R&D expense appears as an operating expense, typically broken out as its own line item. Investors and analysts look at this number closely, so accurate classification matters. If you're using accrual accounting, you record the expense when incurred, not when paid.
Can I capitalize any R&D costs under GAAP?
Yes, but the exceptions are narrow. Internal-use software costs can be capitalized once you exit the preliminary project stage under ASC 350-40. Equipment with alternative future uses gets capitalized and depreciated. Software developed for external sale can be capitalized after technological feasibility is established. Outside these scenarios, GAAP requires immediate expensing. IFRS under IAS 38 is more permissive with development costs, but most U.S. startups follow GAAP.
How does the R&D tax credit interact with expense recognition?
The federal R&D tax credit under Section 41 doesn't change how you record R&D expense on your books. You still expense costs as incurred under ASC 730. The credit is a tax benefit, reducing your tax liability or, for qualifying small businesses, offsetting payroll taxes. You'll need detailed records of qualified research activities, wages, and supplies to support your claim. Your accounting records feed the credit calculation, which is another reason accurate R&D classification is critical.
What happens to R&D accounting when my startup gets acquired?
If your company is acquired, the buyer accounts for any in-process R&D as an intangible asset at fair value under ASC 805. This is a significant shift from the pre-acquisition treatment where those costs were expensed. The acquirer then either amortizes the intangible over its useful life or writes it off if the project is abandoned. Your own books pre-acquisition don't change, but the treatment on the combined entity's financials will look different.
Should I separate R&D from cost of goods sold?
Yes. R&D expense and COGS serve different purposes on your income statement. R&D reflects spending on future products or features. COGS captures the direct costs of delivering your current product to customers. Mixing them distorts your gross margin and makes it harder for investors to evaluate your business model. Keep them in separate accounts from the start, even if the amounts are small.
Puzzle is the AI-native accounting platform built for startups and the firms that serve them. From SAFEs to stock comp, Puzzle categorizes complex transactions correctly the first time, with a clean audit trail your accountant will actually trust. Spend less time second-guessing journal entries and more time on the work that matters.
